Which of the following are monoclonal antibodies used in cancer therapy?

Prepare for the Cancer Management Test with multiple-choice questions, detailed explanations, and flashcard reviews. Get exam ready with us!

Multiple Choice

Which of the following are monoclonal antibodies used in cancer therapy?

Monoclonal antibodies are lab-made molecules designed to bind specific targets on cancer cells, enabling targeted therapy. Rituximab binds CD20 on B cells; trastuzumab targets the HER2 receptor. Herceptin is simply the brand name for trastuzumab, and Rituxan is the brand name for rituximab. Velcade is not an antibody at all; it’s a proteasome inhibitor used in cancer treatment. Therefore, both Rituximab and trastuzumab are monoclonal antibodies used in cancer therapy, and the pairings that include these two mAbs are correct.

Monoclonal antibodies are lab-made molecules designed to bind specific targets on cancer cells, enabling targeted therapy. Rituximab binds CD20 on B cells; trastuzumab targets the HER2 receptor. Herceptin is simply the brand name for trastuzumab, and Rituxan is the brand name for rituximab. Velcade is not an antibody at all; it’s a proteasome inhibitor used in cancer treatment. Therefore, both Rituximab and trastuzumab are monoclonal antibodies used in cancer therapy, and the pairings that include these two mAbs are correct.

More practice questions